Cancers anthracyclines. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Cell Line Heart Neoplastic Stem Cells Breast HL-60 Cells Cell Nucleus Prostate

Organisms2

Mice, Nude Streptomyces

Diseases47

Breast Neoplasms Neoplasm Metastasis Neoplasms Leukemia P388 Heart Diseases Lung Neoplasms Prostatic Neoplasms Ovarian Neoplasms Stomach Neoplasms Colonic Neoplasms Disease Progression Neoplasm Invasiveness Pancreatic Neoplasms Neoplasm Recurrence, Local Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia L1210 Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Colorectal Neoplasms Rectal Neoplasms Pregnancy Complications, Neoplastic Leukemia Cell Transformation, Neoplastic Endometrial Neoplasms Alopecia Cardiomyopathies Leukemia, Myeloid, Acute Esophageal Neoplasms Head and Neck Neoplasms Liver Neoplasms Adenocarcinoma Neutropenia Mouth Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Small Cell Neoplasms, Radiation-Induced Bone Neoplasms Neoplasms, Second Primary Leukemia, Promyelocytic, Acute Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Recurrence Genital Neoplasms, Female

Chemicals and Drugs73

Anthracyclines Naphthacenes Antibiotics, Antineoplastic Daunorubicin Doxorubicin Aclarubicin Carubicin Epirubicin Idarubicin Antineoplastic Agents Taxoids Razoxane Nogalamycin Bridged Compounds Receptor, erbB-2 Fluorouracil Vinblastine DNA Topoisomerases, Type II Paclitaxel Aconitic Acid Antineoplastic Agents, Phytogenic P-Glycoprotein Deoxycytidine Anthraquinones Cyclophosphamide Mitoxantrone Neoplasm Proteins Dexrazoxane Antigens, Neoplasm Cardiotoxins Receptors, Estrogen Cancer Vaccines Tumor Markers, Biological Cisplatin DNA, Neoplasm Antibodies, Monoclonal, Humanized Topoisomerase II Inhibitors RNA, Messenger Antimetabolites, Antineoplastic Etoposide Receptors, Progesterone Verapamil Antibodies, Monoclonal Liposomes Cytarabine Mitomycin Vincristine DNA-Binding Proteins Methotrexate Intercalating Agents Prostate-Specific Antigen RNA, Small Interfering Multidrug Resistance-Associated Proteins Tumor Suppressor Protein p53 Leukotriene C4 Tamoxifen Tetrazolium Salts Trifluoperazine Phthalic Acids Calreticulin Antineoplastic Agents, Hormonal Epothilones Enzyme Inhibitors Antineoplastic Agents, Alkylating Glycosides DNA Anticarcinogenic Agents Lactoperoxidase Receptor, Epidermal Growth Factor MicroRNAs Cardiotonic Agents Asparaginase Tumor Suppressor Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment48

Antineoplastic Combined Chemotherapy Protocols Early Detection of Cancer Chemotherapy, Adjuvant Disease-Free Survival Survival Analysis Drug Administration Schedule Treatment Outcome Survival Rate Prognosis Drug Screening Assays, Antitumor Retrospective Studies Follow-Up Studies Neoplasm Staging Risk Assessment Prospective Studies Combined Modality Therapy Clinical Trials as Topic Multivariate Analysis Salvage Therapy Risk Factors Kaplan-Meier Estimate Risk Reverse Transcriptase Polymerase Chain Reaction Infusions, Intravenous Radiotherapy Gene Expression Profiling Registries Xenograft Model Antitumor Assays Predictive Value of Tests Drug Delivery Systems Transfection Neoplasm Transplantation Remission Induction Blotting, Western Odds Ratio Logistic Models Flow Cytometry Transplantation, Heterologous Sensitivity and Specificity Mammography Oligonucleotide Array Sequence Analysis Questionnaires Tumor Burden SEER Program Molecular Targeted Therapy Polymerase Chain Reaction Maximum Tolerated Dose Reproducibility of Results

Psychiatry and Psychology1

Phenomena and Processes40

Drug Resistance, Neoplasm Drug Resistance, Multiple Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Cell Survival Drug Resistance Apoptosis Mutation Genetic Predisposition to Disease Risk Genes, erbB-2 Cell Cycle Cell Division Time Factors Drug Interactions Drug Synergism Transfection Gene Amplification Odds Ratio DNA Damage DNA Methylation Structure-Activity Relationship Sensitivity and Specificity Genotype Cell Movement Cell Death Genes, BRCA1 Down-Regulation Signal Transduction Polymorphism, Genetic Biotransformation Cell Proliferation Cell Growth Processes Promoter Regions, Genetic Maximum Tolerated Dose RNA Interference Up-Regulation Gene Silencing Genes, Tumor Suppressor Germ-Line Mutation

Disciplines and Occupations1

Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture1

Information Science5

Survival Rate Registries Molecular Sequence Data Questionnaires SEER Program

Named Groups1

Health Care24

Disease-Free Survival Survival Analysis Treatment Outcome Survival Rate Retrospective Studies Follow-Up Studies Risk Assessment Prospective Studies Clinical Trials as Topic Multivariate Analysis Risk Factors National Cancer Institute (U.S.)Kaplan-Meier Estimate Risk Registries Predictive Value of Tests Odds Ratio Age Factors Logistic Models Sensitivity and Specificity Questionnaires SEER Program American Cancer Society Reproducibility of Results

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Anthracyclines Naphthacenes Antibiotics, Antineoplastic Daunorubicin Doxorubicin Aclarubicin Breast Neoplasms Carubicin Epirubicin Idarubicin Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Taxoids Early Detection of Cancer Razoxane Drug Resistance, Neoplasm Neoplasm Metastasis Nogalamycin Neoplasms Bridged Compounds Receptor, erbB-2 Leukemia P388 Chemotherapy, Adjuvant Heart Diseases Fluorouracil Vinblastine Drug Resistance, Multiple DNA Topoisomerases, Type II Lung Neoplasms Paclitaxel Disease-Free Survival Aconitic Acid Antineoplastic Agents, Phytogenic Prostatic Neoplasms Survival Analysis Ovarian Neoplasms Drug Administration Schedule P-Glycoprotein Deoxycytidine Survivors Treatment Outcome Stomach Neoplasms Colonic Neoplasms Cell Line, Tumor Gene Expression Regulation, Neoplastic Survival Rate Dose-Response Relationship, Drug Prognosis Anthraquinones Cyclophosphamide Mitoxantrone Disease Progression Neoplasm Proteins Neoplasm Invasiveness Dexrazoxane Cell Survival Drug Screening Assays, Antitumor Antigens, Neoplasm Pancreatic Neoplasms Retrospective Studies Tumor Cells, Cultured Cardiotoxins Follow-Up Studies Receptors, Estrogen Mice, Nude Cancer Vaccines Neoplasm Staging Tumor Markers, Biological Risk Assessment Drug Resistance Neoplasm Recurrence, Local Cisplatin DNA, Neoplasm Prospective Studies Antibodies, Monoclonal, Humanized Apoptosis Combined Modality Therapy Topoisomerase II Inhibitors RNA, Messenger Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia L1210 Clinical Trials as Topic Mutation Uterine Cervical Neoplasms Multivariate Analysis Genetic Predisposition to Disease Antimetabolites, Antineoplastic Etoposide Salvage Therapy Risk Factors Receptors, Progesterone Verapamil Antibodies, Monoclonal Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell National Cancer Institute (U.S.)Kaplan-Meier Estimate Risk

No FAQ available that match "cancers anthracyclines"